Cannabis Report across cannabis plants
(Source: File image)

Cannabix Technologies Inc. reported that it has been granted a patent from the United States Patent and Trademark Office (USPTO) for its contact-free breath analysis device. This patent is centred on innovations made by Cannabix and its dual mode contactless (and traditional mouthpiece) breath capture and analysis technology used inside the Company’s BreathLogix device platform and holds the potential for wide-ranging utility.

(Source: Cannabix Technologies Inc.)

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | PharmaDrug to acquire equity interest in Canurta

2 | Ayurcann reports record fiscal year sales, 21 per cent year-over-year increase

3 | Herbal Dispatch brings on an industry veteran as an advisor


Top Cannabis Stocks Oct. 24 to Oct. 30, 2025

1. T.CURA | 4,012 views | Curaleaf Holdings Inc.
2. T.TLRY| 3,376 views | Tilray Brands Inc.
3. T.LABS | 2,321 views | Medipharm Labs Corp.
4. T.WEED | 1,732 views | Canopy Growth Corp.
5. T.OGI | 394 views | Organigram Global Inc.
6. C.BLO | 362 views | Cannabix Technologies Inc.


Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.



More From The Market Online

@ the Bell: Markets steady ahead of key rate decisions

Canada’s main stock index was muted on Tuesday as investors held back, awaiting key policy decisions...

Netflix’s blockbuster bid for Warner Bros., and Paramount Skydance’s hostile counter

Netflix (NASDAQ:NFLX) agreed to acquire Warner Bros. Discovery (NASDAQ:WBD) for US$27.75 per share (cash + stock), valuing the deal at US$82.7B

Micron is getting out of the consumer business when it is needed the most

Micron Technology (NASDAQ:MU) will exit its Crucial consumer business, ending sales of Crucial-branded products.